Premium
Visualization of β‐amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents
Author(s) -
Lee SangPil,
Falangola Maria F.,
Nixon Ralph A.,
Duff Karen,
Helpern Joseph A.
Publication year - 2004
Publication title -
magnetic resonance in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.696
H-Index - 225
eISSN - 1522-2594
pISSN - 0740-3194
DOI - 10.1002/mrm.20196
Subject(s) - pathology , genetically modified mouse , amyloid (mycology) , hippocampus , alzheimer's disease , amyloid precursor protein , contrast (vision) , in vivo , thalamus , medicine , transgene , chemistry , neuroscience , biology , disease , biochemistry , computer science , microbiology and biotechnology , gene , artificial intelligence
The visualization of β‐amyloid plaque deposition in brain, a key feature of Alzheimer's disease (AD), is important for the evaluation of disease progression and the efficacy of therapeutic interventions. In this study, β‐amyloid plaques in the PS/APP transgenic mouse brain, a model of human AD pathology, were detected using MR microscopy without contrast reagents. β‐Amyloid plaques were clearly visible in the cortex, thalamus, and hippocampus of fixed brains of PS/APP mice. The distribution of plaques identified by MRI was in excellent agreement with those found in the immunohistological analysis of the same brain sections. It was also demonstrated that image contrast for β‐amyloid plaques was present in freshly excised nonfixed brains. Furthermore, the detection of β‐amyloid plaques was achieved with a scan time as short as 2 hr, approaching the scan time considered reasonable for in vivo imaging. Magn Reson Med 52:538–544, 2004. © 2004 Wiley‐Liss, Inc.